Explaining and analyzing the supply chain risks of Iran's pharmaceutical industry using the combined approach of meta-synthesis and thematic analysis.

Safavi Mirmahalleh, Seyed Rahim; Ramazanian, Mohammad Rahim; Moradi, Mahmoud; Ebrahimpour, Mostafa

Document Type : Original Article

Authors

¹ Ph.D. Candidate, Department of Industrial and Commercial Management, Faculty of Management and Economics, University of Guilan

² Associate Prof. Department of Industrial and Commercial Management, Faculty of Management and Economics, University of Guilan

Abstract

Introduction: The goal of this paper to explain and analyze the supply chain risks of Iran's pharmaceutical industry. In this research, the combined approach of meta-synthesis and thematic analysis has been used.
Methodology: The approach of this research is qualitative. In the first stage, with a systematic review of related studies in the last 23 years with a meta- synthesis approach, supply chain risks in the pharmaceutical industry were identified. For this purpose, first 100 articles were selected and after several stages of filtering, 26 final articles remained and became the basis of the research. In the next step, the supply chain risks of Iran's pharmaceutical industry were obtained by thematic analysis method. For this purpose, a semi-structured interview of Iranian pharmaceutical industry informants was conducted using the method of purposeful sampling and theoretical analysis, with thematic analysis approach. In the last stage, by combining the results of meta-synthesis and thematic analysis, its validity analysis with the method of Content validity ratio, ten risks were obtained as the final risks of Iran's pharmaceutical industry.
Results and Discussion: Based on the results, the supply chain risks of Iran's pharmaceutical industry in order of priority are: environmental risks; problems of foreign currency supply and financial payments; lack of timely supply of raw materials; the complexity and incompatibility of information systems; low quality of raw materials and products; unavailability of medicine and its timely delivery; transportation and insurances; distribution sector technologies; Fluctuations in demand; Increase in the price of raw materials and medicine.
Conclusion: Out of the ten risks obtained, environmental risks, problems of foreign exchange and financial payments, increase in the price of raw materials and medicine, and transportation and insurance, (due to having the highest frequency in both methods of meta-synthesis and thematic analysis) have a greater impact on the supply chain. Therefore, the stakeholders of Iran's pharmaceutical supply chain should focus on these risk factors and plan for their management in order to improve the performance of the supply chain.

Keywords

References

[1] Azar, Adel; and Khorrami, Amir; 2019,“Designing the Resilience Model of the Supply Chain of the Pharmaceutical Industry in Crisis with the Interpretive Structural Modeling (ISM) Approach”. International Business Management.Faculty of Economics and Management, Tabriz University.3 (10):1-31, DOI:10.22034/jiba.2020.11197, [in Persian].

[2] Jaberidoost, M; Abdollahiasl, A; Farshchi, A; and Dinarvand, R. 2013,“Risk management in Iranian pharmaceutical companies to ensure accessibility and quality of medicines”. Value Health, (15), A616–A617.

[3] Beykzadeh Abbasi, Farzaneh. 2022,”Comprehensive risk management model (case study: pharmaceutical industry). Investment Knowledge, 13(50): 73-93, [in Persian].

[4] Guderzi, Fatemeh; 2013,“Designing Supply Chain Risk Reduction Strategies in the Pharmaceutical Industry in Iran”, Master's Thesis, University of Science and Culture, Faculty of Humanities, 2013, Tehran, [in Persian].

[5] Jantian, Nasibeh; Zandieh, Mustafa; Alam Tabriz, Akbar; and Rabieh, Masoud; 2018,”Presentation of the optimization model of sustainable drug distribution network and the use of multi-objective evolutionary algorithms to solve it (Case of study: Daropakhsh Distribution Company)”, Scientific-Research Quarterly of Production and Operations Management, Volume 10, 18(1): 133-153.

[6] Kalai, Fatemeh; 2013,“Identification and analysis of supply chain risk in the pharmaceutical industry with a fuzzy fmea approach (case study of the supply pharmaceutical investment company)”, master's thesis of theNon-Governmental Non-Profit Institute of Higher Education, supervisors: Akbar Alam, Tabriz, Kiomerth Bahraini, Tehran, [in Persian].

[7] Sadeghi Moghadam, Mahreza; Karimi, Toraj; Bensi, Sahar (2017), "Assessment of service supply chain risks with RAF set theory approach (case study: companies providing payment services to banks)", Journal of Management Research in Iran, Volume 22, Number 1, 69-94, DOR: 20.1001.1.2322200.1397.22.1.4.3 [in Persian].

[8] Delfan, Anis; Arefnejad, Mohsen; and Mirzaei, Habib; 2017,”Identification and classification of supply chain risk factors in the nylon thread industry of Parsilon Company”, the first management, accounting and industrial engineering conference. August, Tehran, [in Persian].

[9] Azizi Youssef Vand, Ruqiya; Nahavandi, Nasim; and Farzadi, Gholamhossein; (2016) ,”Investigating the effect of supply chain risk management on the efficiency of drug distribution companies”, International Journal of Industrial Engineering and Production Management of University of Science and Technology, (1)28: pp. 120-137, URL:http://ijiepm.iust.ac.ir, [in Persian].

[10] Zand Hsseami, H; and Savoji, A; 2012,”Risk Management in Supply Chain Management”, International Journal of Economics and Management Sciences, 1(3): 60-72.

[11] Rahimian, Mohammad Mahdi; and Rajabzadeh Qatari, Ali; 2017,”measuring the resilience of the supply chain with the approach of complex adaptive systems; Case Study: Pharmaceutical Industry of Iran”, Research Quarterly Journal of New Researches in Decision Making, 2(2):155-195, [in Persian].

[12] Pitta, D. A., and Laric, M. V; 2004,” Value chains in health care”, Journal of Consumer Marketing, 21(7): 451-464, DOI:10.1108/07363760410568671.

[13] Laeequddin, Mohammed, B.S. Sahay, Vinita Sahay and K. Abdul Waheed; 2010,”Measuring trust in supply chain partners,” relationships Measuring Business Excellence,14 (3): 53-69, DOI:10.1108/13683041011074218.

[14] Shahabi, Vahid; Azar, Adel; Faezi Razi, Farshad; and Falah Shams, Mir Faiz; 2022,”Analysis of factors affecting the development of the supply chain of banking services in the fourth industrial revolution,” Journal of Management Research in Iran, 26(2), 95-114, DOR: 20.1001.1.2322200.1401.26.2.5.4, [in Persian].

[15] Hayati, Mohammad; Atai, Mohammad; Khalukakaei, Reza; and Sayadi, Ahmadreza (2013),“risk assessment and ranking in the supply chain using the taxonomy analysis method (case study: Isfahan Iron Smelting Complex)”, Journal of Operations Research in its Applications, 11(1) (series 40): 85- 103, URL: http://jamlu.liau.ac.ir, [in Persian].

[16] Hosseinzadeh, Mahnaz, Mehrgan, Mohammad Reza, and Qomi, Mohammad; 2018,”Identification and analysis of supply chain risks of Saipa Automobile Company using Kuzo model and Social Network Analysis (SNA) approach”, Production and Operations Management, (18):111 -132, DOI: 10.22108/jpom.2018.107972.1093; DOR: 20.1001.1.22516409.1398.10.1.7.9 [in Persian].

[17] Ghadge, A; and Dani, S; 2012,”Supply chain risk management: present and future scope”, The International Journal of Logistics Management, 23(3): 313-339.

[18] Mehr Ali Dehnavi, Masoumeh, 2011,”risk management in the supply chain”, thesis of Khwaje Nasiruddin Toosi University, supervisor: Abdallah Aghaei, Tehran, [in Persian].

[19] Lee, J; 2011,” 10 year retrospect on stage models of e-Government: A qualitative meta-synthesi”, Government information quarterly, 27(3): 220-230.

[20] Erwin, E .J., Brotherson, M. J., and Summers, J. A; 2011,”Understanding qualitative metasynthesis: Issues and opportunities in early childhood intervention research”, Journal of Early Intervention, 33(3):186- 200.

[21] Sandelowski, M., and Barroso, J; 2006,” Handbook for synthesizing qualitative research,” Springer publishing company.

[22] Moktadir, M.A., Ali, S.M., Mangla, S.K., Sharmy, T.A., Luthra, S., Mishra, N. and Garza-Reyes, J.A; 2018,”Decision modeling of risks in pharmaceutical supply chains”, Industrial Management & Data Systems, 118(7):1388-1412, DOI: https://doi.org/10.1108/IMDS-10-2017-0465

[23] Sharma, A., Kumar, D. and Arora, N; 2023,”Analyzing pharmaceutical industry risks under uncertainty for performance improvement: an Indian scenario”, Business Process Management Journal, 29(7):1961-1988, DOI: https://doi.org/10.1108/BPMJ-03-2023-0203.

[24] Senna, P., Reis, A., Santos, I.L., Dias, A.C. and Coelho, O; 2021,”A systematic literature review on supply chain risk management: is healthcare management a forsaken research field?”, Benchmarking: An International Journal, 28(3): 926-956, DOI: https://doi.org/10.1108/BIJ-05-2020-0266

[25] Moradi, Mojtabi; and Mirzadeh, Mohammad Ali; 2018,”Identification, evaluation and ranking of production risks in the pharmaceutical industry using the failure factor analysis method (case study: Subhan Daru Company)”, Health and Treatment Management (Nizam Salamat), 10(1):43-52, [in Persian].

[26] Bayat, Mahdi, and Khushalhan; Farid; 2016,”Identifying and documenting risk events in the supply chain: the case study of Razi Broadcasting Company”, the first international risk management congress, Tehran, [in Persian].

[27] Ouabouch, Lhoussaine; and Amri, Mostapha; 2017,”Analysing Supply Chain Risk Factors: A Probability-Impact Matrix Applied to Pharmaceutical Industry”, Journal of Logistics M anagement, 2(2):35-40, DOI: 10.5923/j.logistics.20130202.01.

[28] Mehraliana, Gholamhossein; Rajabzadeh Gatarib, Ali. Morakabati, Mohadese and Vatanpour, Hossein, 2012,”Developing a Suitable Model for Supplier Selection Based on Supply Chain Risks: An Empirical Study from Iranian Pharmaceutical Companies”, Iranian Journal of Pharmaceutical Research, 11 (1): 209-219.

[29] Osorio Gómez, Juan Carlos; and Torres España, Katherine; 2020,”Operational Risk Management in the Pharmaceutical Supply Chain Using Ontologies and Fuzzy QFD”, 30th International Conference on Flexible Automation and Intelligent Manufacturing (FAIM2021), Procedia Manufacturing, 51:1673-1679.

[30] Daoud BenAmor .W; Labella. A; Moalla Frikha. H; and Martínez López. L; 2022,”Pharmaceutical Supply chain Risk Assessment During COVID-19 Epidemic”, 10th IFAC Conference on Manufacturing Modelling, Management and Control, Conference Paper, IFAC-PapersOnLine, 55(10):2203-2208, DOI: https://doi.org/10.1016/j.ifacol.2022.10.035.

[31] Eirill Bø; Inger Beate Hovi; and Daniel Ruben Pinchasik; 2023,”COVID-19 disruptions and Norwegian food and pharmaceutical supply chains: Insights into supply chain risk management”, resilience, and reliability, Sustainable Futures; 5:1-11, DOI: https://doi.org/10.1016/j.sftr.2022.100102.

[32] Jeanne-Marie, Lawrence; Niamat Ullah, Ibne Hossain; Raed, Jaradat; and Michael, Hamilton; 2020,”Leveraging a Bayesian network approach to model and analyze supplier vulnerability to severe weather risk: A case study of the U.S. pharmaceutical supplychain following Hurricane Maria”, The International Journal of Disaster Risk Reduction (IJDRR), 49:1-19, DOI: https://doi.org/10.1016/j.ijdrr.2020.101607.

[33] Izadi, Bahram; and Shafiei, Mahbobeh; 2017,”Providing a decision support system in order to evaluate and prioritize the risk of importing goods in order to manage the effects of embargo (case study: import of pharmaceutical items by Farabi Pharmaceutical Company)”, Research in Production and Operations Management, 9(1):79-106, DOI:10.22108/jpom.2018.92395.0, [in Persian].

[34] Jaberidoost, Mona; Nikfar, Shekoufeh; Abdollahiasl, Akbar; and Dinarvand, Rassoul; 2013,”Pharmaceutical supply chain risks: a systematic review”, DARU Journal of Pharmaceutical Sciences (Springer), 21(1): 69, DOI: 10.1186/2008-2231-21-69

[35] Jaberidoost, Mona; Olfat, Laya; Hosseini, Alireza; Kebriaeezadeh, Abbas; and Abdollahi, Mohammad; 2015,”Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods”, Journal of Pharmaceutical Policy and Practice, 8(1)9:1-10, DOI: 10.1186/s40545-015-0029-3

[36] Khorashadizadeh, Seyedah Sara, Hekat Mofared, Jalal, Afshar Kazemi, Mohammad Ali, and Yazdani, Shahram; 2023,”Proposing a comprehensive classification for pharmaceutical industry supply chain risks”, Industrial management studies, DOI: 10.22054/jims.2023.72426.2844.

[37] Panje Kobi, Rahale, Firozi, and Jahantigh, Farzad;2021,”Identification and evaluation of risk factors in the supply chain of pharmaceutical industries using artificial intelligence”, Hospital Quarterly, 20(4):42-50

[38] Claudia Sabate, Martínez; Leanne, Amery; Giorgia, De Paoli; Ulla, Elofsson; Anna Millqvist, Fureby; Stanley, Kwok; Carmen, Lopez-Cabezas; Marika, Rosenberger; Christian, Schoenau; Marie, Wahlgren; and Mattias, Paulsson; 2023,”Examination of the Protein Drug Supply Chain in a Swedish University Hospital: Focus on Handling Risks and Mitigation Measures”, Journal of Pharmaceutical Sciences, 112(11):2799-2810 DOI: https://doi.org/10.1016/j.xphs.2023.05.003.

[39] Sumaiya, Akter; Binoy, Debnath; and A. B. M. Mainul Bari; 2022,”A grey decision-making trial and evaluation laboratory approach for evaluating the disruption risk factors in the Emergency Life-Saving Drugs supply chains”, Healthcare Analytics, 2:1-13, DOI: https://doi.org/10.1016/j.health.2022.100120.

[40] Zahiri. B, Jula. P, and Tavakkoli-Moghaddam. R, 2017,”Design of a pharmaceutical supply chain network under uncertainty considering perishability and substitutability of products”, Information Sciences, DOI: http://dx.doi.org/10.1016/j.ins.2017.09.046.

[41] Sumit, Paul; Golam, Kabir; Syed Mithun, Ali; and Guoqing, Zhang; 2020,”Examining transportation disruption risk in supply chains: A case study from Bangladeshi pharmaceutical industry”, Research in Transportation Business & Management, 37:1-13, DOI: https://doi.org/10.1016/j.rtbm.2020.100485.

[42] Chris I. Enyinda; Chris H. N. Mbah; and Alphonso Ogbuehi; 2010,”An empirical analysis of risk mitigation in the pharmaceutical industry supply chain: A developing-country perspective”, Published online in Wiley InterScience (www.interscience.wiley.com), Thunderbird International Business Review, 52(1):45-54, DOI: https://doi.org/10.1002/tie.20309.

[43] S. Etezadi, H. Safari, M. Zandieh and A Jafarnejad; 2021,”Developing a Model for Comprehensive Analysis of Productivity in the Service Industry Using the Multi-Grounded Theory Approach”, Research in Production

Explaining and analyzing the supply chain risks of Iran's pharmaceutical industry using the combined approach of meta-synthesis and thematic analysis.

References

References

Volume 28, Issue 3October 2024Pages 1-29

Volume 28, Issue 3
October 2024
Pages 1-29